NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2

Loredana Cifaldi, Rita Maria Pinto, Ippolita Rana, Maurizio Caniglia, Adriano Angioni, Stefano Petrocchi, Caterina Cancrini, Laura Cursi, Giuseppe Palumbo, Alessandra Zingoni, Angela Gismondi, Paolo Rossi, Angela Santoni, Cristina Cerboni

Research output: Contribution to journalArticle

Abstract

NK cell cytotoxicity in Chédiak-Higashi syndrome (CHS) is strongly impaired as lytic granules are not released upon NK-target cell contact, contributing to several defects typical of this severe immunodeficiency. Correction of NK cell defects in CHS should improve the outcome of hematopoietic stem-cell transplantation, proposed as therapy. We investigated NK cell functions in a CHS patient before and after cord-blood transplantation, and the ability of in vitro IL-2 treatment to restore them. Before the transplant, the strong defect in NK cell-mediated natural and antibody-dependent cytotoxicity, as well as in IFN-γ production, could be restored up to normal levels by in vitro IL-2 treatment. This cytokine also caused the appearance of smaller lysosomal granules and their orientation towards the NK-target cell contact area, thus suggesting that IL-2 had a more general capacity to restore NK cell effector functions. Moreover after the transplant, although the successful engraftment, NK cell cytotoxicity resulted still partially impaired at one year, almost normal at ten years and, anyhow, fully recovered by in vitro IL-2 treatment. Taken together, our results indicate that IL-2 had a wide capacity to restore NK cell effector functions, being able to reverse the altered cytotoxic activity, lytic granule pattern, and cytokine production observed in the CHS patient.

Original languageEnglish
Pages (from-to)46-53
Number of pages8
JournalImmunology Letters
Volume180
DOIs
Publication statusPublished - Dec 1 2016

Fingerprint

Fetal Blood
Natural Killer Cells
Interleukin-2
Transplantation
Therapeutics
Cytokines
Transplants
In Vitro Techniques
Hematopoietic Stem Cell Transplantation
Antibodies

Keywords

  • Cellular immunology
  • Cord blood transplantation
  • Immunodeficiency
  • Interleukin 2
  • NK cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation : Effects of in vitro treatment with IL-2. / Cifaldi, Loredana; Maria Pinto, Rita; Rana, Ippolita; Caniglia, Maurizio; Angioni, Adriano; Petrocchi, Stefano; Cancrini, Caterina; Cursi, Laura; Palumbo, Giuseppe; Zingoni, Alessandra; Gismondi, Angela; Rossi, Paolo; Santoni, Angela; Cerboni, Cristina.

In: Immunology Letters, Vol. 180, 01.12.2016, p. 46-53.

Research output: Contribution to journalArticle

Cifaldi, Loredana ; Maria Pinto, Rita ; Rana, Ippolita ; Caniglia, Maurizio ; Angioni, Adriano ; Petrocchi, Stefano ; Cancrini, Caterina ; Cursi, Laura ; Palumbo, Giuseppe ; Zingoni, Alessandra ; Gismondi, Angela ; Rossi, Paolo ; Santoni, Angela ; Cerboni, Cristina. / NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation : Effects of in vitro treatment with IL-2. In: Immunology Letters. 2016 ; Vol. 180. pp. 46-53.
@article{949a740449c943acaec8879c3399ad3c,
title = "NK cell effector functions in a Ch{\'e}diak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2",
abstract = "NK cell cytotoxicity in Ch{\'e}diak-Higashi syndrome (CHS) is strongly impaired as lytic granules are not released upon NK-target cell contact, contributing to several defects typical of this severe immunodeficiency. Correction of NK cell defects in CHS should improve the outcome of hematopoietic stem-cell transplantation, proposed as therapy. We investigated NK cell functions in a CHS patient before and after cord-blood transplantation, and the ability of in vitro IL-2 treatment to restore them. Before the transplant, the strong defect in NK cell-mediated natural and antibody-dependent cytotoxicity, as well as in IFN-γ production, could be restored up to normal levels by in vitro IL-2 treatment. This cytokine also caused the appearance of smaller lysosomal granules and their orientation towards the NK-target cell contact area, thus suggesting that IL-2 had a more general capacity to restore NK cell effector functions. Moreover after the transplant, although the successful engraftment, NK cell cytotoxicity resulted still partially impaired at one year, almost normal at ten years and, anyhow, fully recovered by in vitro IL-2 treatment. Taken together, our results indicate that IL-2 had a wide capacity to restore NK cell effector functions, being able to reverse the altered cytotoxic activity, lytic granule pattern, and cytokine production observed in the CHS patient.",
keywords = "Cellular immunology, Cord blood transplantation, Immunodeficiency, Interleukin 2, NK cells",
author = "Loredana Cifaldi and {Maria Pinto}, Rita and Ippolita Rana and Maurizio Caniglia and Adriano Angioni and Stefano Petrocchi and Caterina Cancrini and Laura Cursi and Giuseppe Palumbo and Alessandra Zingoni and Angela Gismondi and Paolo Rossi and Angela Santoni and Cristina Cerboni",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.imlet.2016.10.009",
language = "English",
volume = "180",
pages = "46--53",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",

}

TY - JOUR

T1 - NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation

T2 - Effects of in vitro treatment with IL-2

AU - Cifaldi, Loredana

AU - Maria Pinto, Rita

AU - Rana, Ippolita

AU - Caniglia, Maurizio

AU - Angioni, Adriano

AU - Petrocchi, Stefano

AU - Cancrini, Caterina

AU - Cursi, Laura

AU - Palumbo, Giuseppe

AU - Zingoni, Alessandra

AU - Gismondi, Angela

AU - Rossi, Paolo

AU - Santoni, Angela

AU - Cerboni, Cristina

PY - 2016/12/1

Y1 - 2016/12/1

N2 - NK cell cytotoxicity in Chédiak-Higashi syndrome (CHS) is strongly impaired as lytic granules are not released upon NK-target cell contact, contributing to several defects typical of this severe immunodeficiency. Correction of NK cell defects in CHS should improve the outcome of hematopoietic stem-cell transplantation, proposed as therapy. We investigated NK cell functions in a CHS patient before and after cord-blood transplantation, and the ability of in vitro IL-2 treatment to restore them. Before the transplant, the strong defect in NK cell-mediated natural and antibody-dependent cytotoxicity, as well as in IFN-γ production, could be restored up to normal levels by in vitro IL-2 treatment. This cytokine also caused the appearance of smaller lysosomal granules and their orientation towards the NK-target cell contact area, thus suggesting that IL-2 had a more general capacity to restore NK cell effector functions. Moreover after the transplant, although the successful engraftment, NK cell cytotoxicity resulted still partially impaired at one year, almost normal at ten years and, anyhow, fully recovered by in vitro IL-2 treatment. Taken together, our results indicate that IL-2 had a wide capacity to restore NK cell effector functions, being able to reverse the altered cytotoxic activity, lytic granule pattern, and cytokine production observed in the CHS patient.

AB - NK cell cytotoxicity in Chédiak-Higashi syndrome (CHS) is strongly impaired as lytic granules are not released upon NK-target cell contact, contributing to several defects typical of this severe immunodeficiency. Correction of NK cell defects in CHS should improve the outcome of hematopoietic stem-cell transplantation, proposed as therapy. We investigated NK cell functions in a CHS patient before and after cord-blood transplantation, and the ability of in vitro IL-2 treatment to restore them. Before the transplant, the strong defect in NK cell-mediated natural and antibody-dependent cytotoxicity, as well as in IFN-γ production, could be restored up to normal levels by in vitro IL-2 treatment. This cytokine also caused the appearance of smaller lysosomal granules and their orientation towards the NK-target cell contact area, thus suggesting that IL-2 had a more general capacity to restore NK cell effector functions. Moreover after the transplant, although the successful engraftment, NK cell cytotoxicity resulted still partially impaired at one year, almost normal at ten years and, anyhow, fully recovered by in vitro IL-2 treatment. Taken together, our results indicate that IL-2 had a wide capacity to restore NK cell effector functions, being able to reverse the altered cytotoxic activity, lytic granule pattern, and cytokine production observed in the CHS patient.

KW - Cellular immunology

KW - Cord blood transplantation

KW - Immunodeficiency

KW - Interleukin 2

KW - NK cells

UR - http://www.scopus.com/inward/record.url?scp=84994620505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994620505&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2016.10.009

DO - 10.1016/j.imlet.2016.10.009

M3 - Article

AN - SCOPUS:84994620505

VL - 180

SP - 46

EP - 53

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

ER -